Over the last years, many biological markers emerged that act as an adjunct for the detection of early bladder cancer recurrence. Some of these markers had a proven better sensitivity and ...

Formula 1 legend Eddie Jordan has died from cancer ... Way back in March and April, I was diagnosed with bladder and prostate cancer, and then it spread into the spine and the pelvis, so it ...

The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% [101] Association ... association with stage III–IV disease.

For bladder cancer, about 80 per cent of people survive their cancer for five years or more after a stage 1 diagnosis ... and 10 per cent for stage 4. Treatment for both will depend on several ...

Currently it is in Phase III stage of clinical trial for the treatment of Bladder Cancer. APL 1202 : Asieris Pharmaceuticals APL-1202 is an orally available reversible MetAP2 Inhibitor with anti ...

Imfinzi is being tested across early- and late-stage bladder cancer in various treatment combinations, including in non-muscle invasive disease in the POTOMAC study, MIBC patients who are ...

Imfinzi is approved in combination with gemcitabine and cisplatin as a neoadjuvant treatment for muscle-invasive bladder ... approved for stage III non-small cell lung cancer, extensive-stage ...